Profound Medical (PROF) Cost of Revenue (2019 - 2026)
Profound Medical has reported Cost of Revenue over the past 7 years, most recently at $2.0 million for Q4 2025.
- For Q4 2025, Cost of Revenue rose 63.59% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $4.7 million, up 29.15%, while the annual FY2025 figure was $4.7 million, 29.15% up from the prior year.
- Cost of Revenue for Q4 2025 was $2.0 million at Profound Medical, up from $1.4 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $2.0 million in Q4 2025 and troughed at $459000.0 in Q1 2021.
- A 5-year average of $940800.0 and a median of $870000.0 in 2022 define the central range for Cost of Revenue.
- On a YoY basis, Cost of Revenue climbed as much as 131.31% in 2021 and fell as far as 71.16% in 2021.
- Year by year, Cost of Revenue stood at $501000.0 in 2021, then soared by 39.32% to $698000.0 in 2022, then surged by 46.13% to $1.0 million in 2023, then rose by 19.02% to $1.2 million in 2024, then soared by 63.59% to $2.0 million in 2025.
- Business Quant data shows Cost of Revenue for PROF at $2.0 million in Q4 2025, $1.4 million in Q3 2025, and $593000.0 in Q2 2025.